Multi-Tissue Organoid Better Predicts Human Response to Drug Treatments: CellCipher

CellCipher has developed a new type of organoid model that captures nearly 70 different cell types to enable drug discovery and personalized medicine. In vitro human models, including organoids…

Two UChicago Startups Receive Investment from the George Shultz Innovation Fund

The George Shultz Innovation Fund (fall 2023 cycle) has awarded $200,000 to NetMicroscope and $150,000 to CellCipher to further develop their work. Managed by the Polsky Center for Entrepreneurship and…

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept